---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-100455"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:21:10.882731+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma grants 184,492 stock options to five executive officers at $3.01 strike

## Summary
- CEO Iain Dukes: 64,839 options; CFO Parker, CSO Pauza, CMO Redfield each 32,406; COO Savchuk 22,435.
- Exercise price $3.01/share (Oct 10 closing); 10-year term; full vest on first anniversary (Oct 12, 2026).
- Granted under Amended and Restated 2021 Incentive Compensation Plan; subject to continued service.

## SEC filing metadata
- accession: 0001104659-25-100455
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/0001104659-25-100455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/tm2528641d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-100455
- JSON: https://secwatch.observer/filing/0001104659-25-100455.json
- Plain text: https://secwatch.observer/filing/0001104659-25-100455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.